
Sun Pharmaceutical Industries
Market cap
$55.0b
Enterprise value
$51.7b
Share price
INR1665.90 SUNPHARMA.NS
- Healthcare
- pharmaceutical
Get premium to view all results
Date | Investors | Amount | Round |
---|---|---|---|
N/A | €0.0 | round | |
N/A | Acquisition | ||
Total Funding | 000k |

Nostrum Laboratories(exited)
INR | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | 3 % | 16 % | 13 % | 10 % | 9 % | 10 % | 10 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | 27 % | 30 % | 28 % | 30 % | 33 % | 28 % | 29 % |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | 9 % | 9 % | 20 % | 20 % | 21 % | 22 % | 23 % |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Equity research estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit
Investments by Sun Pharmaceutical Industries
Edit
ACQUISITION by Sun Pharmaceutical Industries Nov 2012

ACQUISITION by Sun Pharmaceutical Industries Sep 2015

ACQUISITION by Sun Pharmaceutical Industries Jan 2023

ACQUISITION by Sun Pharmaceutical Industries Apr 2014

exited

exited

ACQUISITION by Sun Pharmaceutical Industries Nov 2016